48Needs Work

Diagnostic Review: MedElder Medication Tracking & Pharmacy Integration App

CONDITIONAL
Original Idea

MedElder is a medication reminder and tracking app designed for elderly users, featuring simple UI, caregiver alerts, and pharmacy integration.

TAM$1.76 Billion in 2025 (Source: wiseguyreports.com). Calculated as global medication tracker apps market, growing to $6.5B by 2035 at 14% CAGR.
Confidence65%
Growing
Validated Jun 20, 2026·

Executive Summary

48Needs Work
CONDITIONAL

Confidence: 65%

Key Findings

Overall Score: 48/100
Key Signal: MedElder has achieved what 90% of startups fail to do: monetization. This proves the core problem is real and users will pay for a solution. However, the current B2C trajectory is a venture-scale dead end. The fundamental issue is that medication adherence is a 'vitamin' for the consumer (the senior) but a 'painkiller' for the healthcare system (insurers/pharmacies). By charging $5/month to the adult child, you are capturing a fraction of the value you create, while bearing 100% of the customer acquisition cost. The $3.84 physical pill organizer and free PillPack service are your true competitors, not other apps. Your condition for survival and growth is an immediate pivot to B2B2C. You must leverage your existing user data to pitch CMS Remote Therapeutic Monitoring (RTM) billing to regional pharmacies or Medicare Advantage plans. If you cannot secure 3 pilot partnerships with healthcare providers within 6 months to subsidize the app cost, this will remain a low-margin lifestyle business.
Positive Signals: Proven traction: Already at monetization stage, validating baseline willingness to pay and core utility.
Risk Signals: Shallow Moat & Incumbent Threat: Medisafe and others have already won B2C mindshare. Basic reminder features are easily copied, and you lack network effects or proprietary data to defend market share.
Key Evidence: Silver economy valued at $42B in 2024, projected to reach $67B by 2034 (Source: distance.physiology.med.ufl.edu).

Core Questions

How Big?

TAM is $1.76B (wiseguyreports). This is not a $100B mega-market, but it is sufficient for a $50M-$100M venture outcome if you capture the B2B2C RTM workflow. Pure B2C will cap out at $10M.

Why Now?

CMS finalized Remote Therapeutic Monitoring (RTM) reimbursement codes, transforming medication adherence from a consumer convenience into a billable medical event, creating a massive new B2B2C funding pool.

Why You?

No obvious unfair advantage. You must compensate through your existing revenue traction, proving you can execute, and by moving faster than Medisafe into the RTM niche.

How Hard?

Extremely hard to defend in B2C (zero switching costs). The only defensible moat is deep, exclusive integration into a regional pharmacy chain's workflow, creating high switching costs for the provider.

Why This?

Users currently use $3.84 plastic organizers or free PillPack. MedElder must prove that the caregiver's peace-of-mind and automated pharmacy refills justify a recurring fee and behavior change over a one-time physical box.

Executive Summary

MedElder addresses a real, painful problem in a $1.76B growing market, and achieving monetization stage proves initial product-market fit. However, as a pure B2C medication reminder app, it faces a fatal structural flaw: the physical status quo ($3.84 pill organizers) and free pharmacy services (PillPack) dominate, while the true moat (pharmacy API integration) is controlled by incumbents. To reach venture scale and avoid becoming a lifestyle business, MedElder must pivot from a $5/mo B2C subscription to a B2B2C model leveraging CMS Remote Therapeutic Monitoring (RTM) reimbursements. Without this pivot, unit economics will fail due to high B2C CAC and low ARPU.

Positive Signals (5)

Proven traction: Already at monetization stage, validating baseline willingness to pay and core utility.
Large & growing TAM: Medication tracker apps market valued at $1.76B in 2025, growing at 14% CAGR (Source: wiseguyreports.com).
Demographic tailwind: Silver economy reaching $67B by 2034, with 'Peak 65' generation driving digital adoption.
Policy shift: CMS RTM reimbursement policies create a new B2B2C revenue channel for medication adherence tracking.
Clear UX gap: NIH studies confirm current apps suffer from poor flexibility and navigation, leaving room for a superior, senior-specific UX.

Risk Signals (5)

CriticalShallow Moat & Incumbent Threat: Medisafe and others have already won B2C mindshare. Basic reminder features are easily copied, and you lack network effects or proprietary data to defend market share.
CriticalPharmacy Integration Illusion: Integrating with CVS/Walgreens or PBMs requires massive compliance and BD resources. Pharmacies control the APIs and will likely build this internally or partner with giants rather than a startup.
HighBroken B2C Unit Economics: At ~$5/mo ($60/yr) ARPU, B2C CAC in senior care often exceeds $100. Payback period exceeds 20 months without viral loops or B2B subsidies, making pure B2C unviable for VC returns.
HighLow-Tech Substitution: The $3.84 Amazon 7-day pill organizer and free Amazon PillPack service solve 90% of the adherence problem without requiring app literacy or smartphone ownership from the senior.
MediumUser-Builder Disconnect: The buyer (adult child) and user (elderly parent) are different. NIH data shows elderly users struggle with app navigation, leading to high churn and negative reviews.

Kill Signals

✅Market Monopoly

CR5 market share in medication adherence apps

Threshold: > 70% market share held by top 5 players

❌Unit Economics

B2C LTV:CAC Ratio

Threshold: < 2.0x for 60 consecutive days

⚠️Demand Authenticity

B2B Pilot Conversion Rate

Threshold: 0 signed LOIs from 20 pharmacy outreach attempts

⚠️Technical Feasibility

EHR/Pharmacy API Integration Time

Threshold: > 6 months to achieve first successful data sync

⚠️Compliance Risk

HIPAA Audit Findings

Threshold: Any critical unremediated vulnerabilities blocking B2B sales

✅Timing Risk

CMS RTM Adoption Rate

Threshold: < 5% of eligible providers actively billing RTM by 2026

Detailed Scores

Score Details

85
Problem Score
  • •Problem validated - 3
  • •User pain point is clear, demand exists
  • •Some willingness to pay, but requires education(Current:Physical 7-day pill ...)
60
Solution Score
  • •MVP has high technical risk, needs breakthrough in key technology
  • •Value proposition is vague, needs repositioning
  • •Low resource needs, can start solo
75
Market Score
  • •Target market needs further definition
  • •Market is premature or past peak
  • •Low competition, blue ocean market
  • •Low problem-solution fit, needs rethinking

Scoring Dimensions

The three core scores are based on a comprehensive assessment of the following 9 dimensions

Market Factors (5)

Target Market Clarity8

Target customer definition is vague, need to clarify ICP profile

Market Timing9

Market trend is growing, entry timing is right, higher risk

Entry Barriers4

Low entry barriers, need to build technology or resource moat

Competition Level8

Weak competition, 3 competitors but room for differentiation

Problem-Solution Fit7

Low problem-solution fit, user willingness to pay is 中等, needs rethinking

Execution Factors (4)

MVP Viability9

MVP has high technical risk, needs breakthrough in key technology

Value Proposition6

Value proposition is vague, needs to reposition core selling points

Initial Feasibility8

Cold start is difficult, needs external resources or partners

Resource Requirements5

Low resource needs, 3-4 core members, leveraging contractors for HIPAA compliance audits. is enough to start

Problem Validation

Problem Exists:Yes
Severity:HIGH
Willingness to Pay:MEDIUM
Current Workaround

Physical 7-day pill organizers ($3.84 on Amazon), pre-sorted pharmacy delivery (Amazon PillPack), or manual spreadsheets/alarm clocks.

Evidence
  • -NIH Study: 'inconsistent reminders, poor flexibility of setting reminders, difficulty navigating or using, desire for additional features, and easier input' (Source: PMC5694345).
  • -Reddit r/AgingParents: 'The biggest drawback to this approach is if her medications change frequently. It's better for people who are on a standard regime' (Source: Reddit).
  • -Reddit r/eldercare: 'For validation, you could track missed doses... alert family members if something seems off.' (Source: Reddit).

GO/NO-GO Detail

Rationale

MedElder is solving a real problem in a growing market, and reaching the monetization stage is a strong signal of initial execution. However, the strategic positioning is fundamentally flawed for a venture-backed trajectory. This will likely fail because you are building a horizontal B2C app in a market where the physical status quo ($3.84 pill organizer) and free pharmacy services (Amazon PillPack) solve 90% of the problem. Your proposed moat—pharmacy integration—is an illusion because pharmacies control the inventory and APIs; they will either build this themselves or partner with giants like Medisafe. Without a proprietary B2B2C distribution channel (like direct Medicare RTM billing), your $5/month CAC payback period will exceed 18 months, bleeding cash until you pivot or die. Furthermore, you have no stated unfair advantage in this market. Medisafe has deep pockets, established brand trust, and existing pharmacy integrations. To win, you cannot out-feature them; you must out-distribute them by embedding directly into the reimbursement workflows of healthcare providers. If you remain a pure B2C app, you are building a $2M ARR lifestyle business, not a $100M venture-scale company.

Deal Breakers
  • !Failure to secure at least 2 B2B2C pilot partnerships (pharmacies/insurers) for RTM billing within 6 months.
  • !B2C LTV:CAC remaining below 2.0x after 3 months of optimization.
Key Conditions
  • -Pivot business model from pure B2C subscription to B2B2C subsidized model.
  • -Achieve B2C LTV:CAC > 3.0x by optimizing onboarding and reducing churn.
  • -Integrate with at least one major pharmacy API aggregator (e.g., Health Gorilla) to prove technical feasibility.
  • -Reduce monthly churn from existing paying users to < 5%.
  • -Secure HIPAA compliance and SOC2 certification to enable B2B healthcare sales.

SWOT Analysis

Strengths

  • +Already generating revenue, proving product-market fit.
  • +Simple UI tailored for elderly users addresses NIH-identified pain points.
  • +Caregiver alert system bridges the user-builder disconnect.

Weaknesses

  • !Low ARPU ($5/mo) makes B2C unit economics fragile.
  • !No proprietary data moat or network effects.
  • !Heavy reliance on manual medication entry by users/caregivers.

Opportunities

  • *CMS Remote Therapeutic Monitoring (RTM) reimbursement codes.
  • *Aging 'Peak 65' demographic increasing smartphone adoption.
  • *Partnerships with regional pharmacies needing adherence tracking.

Threats

  • !Medisafe and other well-funded incumbents copying features.
  • !Amazon PillPack and physical pillboxes offering free/cheap alternatives.
  • !Pharmacies walled-gardening their APIs against third-party startups.

Market Analysis

Market Reality

TAM
$1.76 Billion in 2025 (Source: wiseguyreports.com). Calculated as global medication tracker apps market, growing to $6.5B by 2035 at 14% CAGR.
Total Addressable Market
SAM
$670 Million. Estimated 38.1% of the global market attributed to North America (Source: dataintelo.com notes NA is 38.1% of the $8.4B broader device market; applying to app market yields ~$670M).
Serviceable Addressable Market
SOM
$6.7 Million. Achievable 1% market share of SAM within 3-5 years, assuming successful B2B2C pivot and scaling.
Serviceable Obtainable Market
Market Trend:GROWING
Timing Risk:Right Time
Market Evidence
  • -Silver economy valued at $42B in 2024, projected to reach $67B by 2034 (Source: distance.physiology.med.ufl.edu).
  • -Medication Adherence Market expected to reach $10.26B by 2031 at 13.72% CAGR (Source: mordorintelligence.com).

Customer Profile

Primary ICP

Adult children (ages 45-65) acting as primary caregivers for elderly parents (75+) with 3+ daily medications.

Company Types
Regional Pharmacy Chains (B2B)Medicare Advantage Plans (B2B)Home Care Agencies (B2B)
Geographic Focus

North America (specifically US, leveraging CMS RTM policies).

Budget Authority

Adult children (B2C), Pharmacy Owners / Clinic Administrators (B2B).

Buying Process

B2C: Impulse digital purchase via App Store. B2B: 3-6 month pilot sales cycle requiring compliance review.

Competitor Analysis

Competitive Landscape(3 competitors analyzed)
Market Saturation:Moderate
Opportunity Gap:Focus exclusively on the 'Pharmacy Integration + RTM' wedge ...

Competitor Matrix

Pricing
Free with optional premium upgrade.
Strengths
  • Clean, easy-to-use interface.
  • Drug interaction warnings.
  • Family view for remote monitoring.
Weaknesses
  • Premium features are locked behind paywalls.
  • Can feel overwhelming for non-tech-savvy seniors to set up initially.
User Complaints
  • !Occasional sync issues between caregiver and patient apps.
  • !Customer support can be slow to respond to critical missed-dose alerts.
Feature Gaps
Lacks direct, seamless one-click pharmacy refill integration across all chains.No direct billing integration for caregiver time.
Moat
Brand trust, massive existing user data, established pharmacy partnerships.
How We Win
Focus exclusively on the 'Pharmacy Integration + RTM' wedge that Medisafe treats as a secondary feature.
Differentiation
MedElder must win on extreme simplicity for the senior (zero-setup) rather than feature depth for the caregiver.
Pricing
Free basic version. Paid version: $2.99/month or $27.99/year.
Strengths
  • Seamless data synchronization with other users.
  • Medication tracking with refill reminders.
  • Option to upload medication photos for identification.
Weaknesses
  • Lower brand awareness compared to Medisafe.
  • UI/UX is less optimized specifically for the elderly.
User Complaints
  • !Photo identification feature is often inaccurate.
  • !App crashes reported on older Android devices.
Feature Gaps
Lacks robust caregiver alert systems for immediate missed doses.No direct pharmacy API ordering.
Moat
Low. Easily replicable feature set.
How We Win
Superior UX for the 75+ demographic, reducing the setup friction that Dosecast suffers from.
Differentiation
MedElder's UI is specifically designed for elderly cognitive load, whereas Dosecast is more clinical.
Pricing
Gold Plan: $4.99/month. (1-month free trial).
Strengths
  • Smart medication reminders with missed dose family alerts.
  • Overdose protection and refill prescription alerts.
  • Supports up to 4 family members on one account.
Weaknesses
  • Feature bloat (calendar, tasks) might confuse elderly users.
  • Lower app store rating (4.2) indicates UX friction.
User Complaints
  • !Notifications can be delayed or fail to trigger.
  • !Customer support is unresponsive to bug reports.
Feature Gaps
Medication log history is basic.No direct integration with pharmacy inventory systems.
Moat
First-mover advantage in the 'hub' concept, but highly defection-prone.
How We Win
Ruthless simplification. By doing only medication tracking perfectly, we reduce cognitive load for seniors.
Differentiation
MedElder will maintain a strict 'medication-only' focus to avoid the feature bloat that plagues mySeniorCareHub.

Medisafe

Visit Website

Target Users: Adult children managing elderly parents' complex medication regimens.

Traction
Market leader, millions of downloads, highly recommended by caregiver platforms.
Positioning

The most medication-validated platform. Strongest for medication adherence and missed-dose alerts with a 'Medfriend' caregiver feature.

Pricing

Free with optional premium upgrade.

User Complaints

!Occasional sync issues between caregiver and patient apps.

!Customer support can be slow to respond to critical missed-dose alerts.

Feature Gaps
Lacks direct, seamless one-click pharmacy refill integration across all chains.No direct billing integration for caregiver time.
Moat

Brand trust, massive existing user data, established pharmacy partnerships.

How We Win

Focus exclusively on the 'Pharmacy Integration + RTM' wedge that Medisafe treats as a secondary feature.

Dosecast

Visit Website

Target Users: Patients and caregivers wanting detailed progress reports for medical professionals.

Traction
Established player, featured on major health blogs.
Positioning

A medication reminder app focusing on data synchronization and progress reports for doctors.

Pricing

Free basic version. Paid version: $2.99/month or $27.99/year.

User Complaints

!Photo identification feature is often inaccurate.

!App crashes reported on older Android devices.

Feature Gaps
Lacks robust caregiver alert systems for immediate missed doses.No direct pharmacy API ordering.
Moat

Low. Easily replicable feature set.

How We Win

Superior UX for the 75+ demographic, reducing the setup friction that Dosecast suffers from.

Target Users: Families managing senior care, needing a centralized hub for meds and tasks.

Traction
100K+ downloads, 4.2 rating on app stores.
Positioning

A comprehensive senior care app offering medication reminders, voice commands, and family alerts.

Pricing

Gold Plan: $4.99/month. (1-month free trial).

User Complaints

!Notifications can be delayed or fail to trigger.

!Customer support is unresponsive to bug reports.

Feature Gaps
Medication log history is basic.No direct integration with pharmacy inventory systems.
Moat

First-mover advantage in the 'hub' concept, but highly defection-prone.

How We Win

Ruthless simplification. By doing only medication tracking perfectly, we reduce cognitive load for seniors.

Market Intelligence

Case Studies & Transformations

AdhereHealth

HealthTech / Data Analytics

Raised $30M+ in funding, indicating strong B2B traction.
Challenge:Health plans needed to identify patients at risk of medication non-adherence to prevent costly hospital readmissions.
Solution:Built a predictive analytics platform using pharmacy fill data to flag high-risk patients for clinician intervention.
Result:Significantly reduced readmission rates and improved Star Ratings for partner health plans.

Medisafe

Consumer Health App

Estimated $10M-$20M ARR, primarily through B2C premium and B2B pharma partnerships.
Challenge:Creating a sticky consumer app for medication management in a market with low switching costs.
Solution:Focused heavily on the 'Medfriend' caregiver feature and drug interaction warnings to build a strong B2C moat.
Result:Became the most downloaded and highest-rated medication management app globally.

Go-To-Market Playbook

Positioning Statement

The only medication adherence platform built to unlock CMS RTM revenue for pharmacies while protecting elderly patients.

Core Messaging

For Pharmacies: 'Turn medication adherence from an uncompensated chore into a predictable revenue stream.'For Caregivers: 'Know they took it, so you don't have to worry.'For Seniors: 'Your pills, simplified. No setup required.'

Acquisition Channels

Direct B2B Sales (Pharmacies)High

预期 CAC: $0 (Subsidized by provider)

时间线:Months 1-3

Scrape lists of independent and regional pharmacy owners.Attend state-level pharmacy association conferences.Offer a 90-day risk-free RTM revenue pilot.
Caregiver Communities (B2C)Medium

预期 CAC: $80-$120

时间线:Months 3-6

Targeted Facebook/Instagram ads focusing on 'caregiver burnout'.Partnerships with Alzheimer's Association and AARP local chapters.SEO content around 'how to manage elderly parents medications'.

Launch Strategy

Pre-launch (4 weeks)
  • •Secure HIPAA compliance.
  • •Sign 2 regional pharmacy LOIs for pilot.
Launch Day
  • •Announce pilot success via press release in healthcare trade journals (e.g., FiercePharma).
  • •Launch provider referral program (give a month free for every pharmacy referred).
Post-launch Growth
  • •Publish case study on RTM revenue generated for pilot pharmacies.
  • •Expand sales team to target Medicare Advantage plans.

Market Trends Analysis

CMS RTM Reimbursement Expansion

Impact:High

Medicare is increasingly reimbursing for Remote Therapeutic Monitoring, allowing providers to bill for tracking medication adherence.

Opportunity

Creates a direct B2B revenue stream for MedElder, shifting the model from B2C subscription to B2B2C SaaS.

Threat

If CMS changes billing codes or reduces reimbursement rates, the B2B value prop collapses.

Consolidation of Independent Pharmacies

Impact:Medium

Independent pharmacies are forming buying groups and networks to compete with Amazon and CVS.

Opportunity

Selling to a pharmacy network co-op provides distribution to hundreds of locations via a single contract.

Threat

Networks may demand exclusive partnerships or deep discounts, squeezing margins.

Customer Success Metrics

MetricBenchmarkIndustrySource
Medication Adherence Rate (PDC)> 80% (Proportion of Days Covered)Healthcare / PharmacyCMS Star Ratings Guidelines
RTM Billing Success Rate> 90% of submitted claims paidMedical BillingIndustry standard for clean claims

Financial Projections

Revenue Models

B2C Freemium Subscription

Fit for This Market: LOW
Estimated MRR
$10,000 (at 2,000 paid users)

Free basic reminders, $4.99/mo for caregiver alerts and pharmacy integration.

Pros
  • +Low friction for initial user acquisition.
  • +Predictable recurring revenue.
Cons
  • !Extremely low ARPU ($60/yr) makes B2C CAC payback impossible.
  • !High churn if senior forgets to use it.
Implementation Steps
  1. 1.Optimize App Store conversion rate.
  2. 2.Implement paywall at caregiver alert setup.

B2B2C SaaS + RTM Billing

Fit for This Market: HIGH
Estimated MRR
$30,000 (at 10,000 patients via 5 clinics)

Provide app for free to patients via pharmacy/clinic. Charge the provider a SaaS fee ($3/patient/mo) + take a % of CMS RTM reimbursement revenue generated.

Pros
  • +Provider subsidizes CAC (B2B distribution).
  • +Aligns incentives with healthcare outcomes.
  • +Much higher LTV.
Cons
  • !Long B2B sales cycles.
  • !Requires heavy compliance (HIPAA, SOC2).
Implementation Steps
  1. 1.Build provider dashboard.
  2. 2.Integrate with EHR systems (Epic/Cerner) via APIs.
  3. 3.Establish RTM billing compliance framework.

Financial Projections

Year 1 Revenue
$480,000. (Math: 4,000 active B2C users * $60 ARPU/yr + 5,000 B2B2C users subsidized by 2 clinics at $36/yr = $240k + $180k + early B2B SaaS fees).
Year 2 Revenue
$1,500,000. (Math: Scaling to 15,000 B2B2C patients via 6 regional pharmacy partners at $60/yr effective yield + 10,000 B2C users).
Year 3 Revenue
$4,200,000. (Math: 50,000 B2B2C patients via 20 partners at $60/yr + 20,000 B2C users).
Break-Even Timeline

14 months from pivot initiation.

Capital Required

$750,000 (Seed round to fund B2B sales team, HIPAA compliance, and EHR integration development).

Unit Economics
Target CAC
$40 (Blended: $0 for B2B2C via provider channel, $120 for B2C digital).
Target LTV
$180 (B2B2C: $5/mo ARPU * 36 months retention).
Target LTV:CAC
4.5x
Key Assumptions
  • -B2B2C pivot is executed within 6 months.
  • -Average retention for B2B2C is 18 months (tied to clinic relationship).
  • -B2C churn remains at 8% monthly; B2B2C churn is 4% monthly.

Risk Assessment

CriticalMarket

Pharmacy API Walled Gardens: Major chains (CVS, Walgreens) may block third-party API access or charge exorbitant fees, rendering the 'pharmacy integration' core value prop dead on arrival.

Mitigation:

Pivot to using pharmacy data aggregators (e.g., Surescripts, Health Gorilla) or focus on independent/regional pharmacies first to build case studies.

CriticalFinancial

B2C Unit Economics Collapse: If B2B2C pivot fails, the pure B2C model will burn cash due to CAC ($100+) exceeding LTV ($60) over a reasonable timeframe.

Mitigation:

Implement a strict kill-switch on B2C paid marketing if LTV:CAC drops below 2.0x for 60 consecutive days.

HighTechnical

EHR Integration Complexity: Connecting with legacy Electronic Health Records (Epic, Cerner) for RTM billing is notoriously difficult and slow, delaying the B2B2C revenue timeline.

Mitigation:

Use established middleware APIs (e.g., Redox, Datica) rather than building direct EHR integrations from scratch.

MediumMarket

Incumbent Feature Parity: Medisafe launches a robust RTM dashboard, neutralizing MedElder's primary B2B differentiator.

Mitigation:

Focus on hyper-local, high-touch onboarding for regional pharmacies that Medisafe's enterprise sales team ignores.

MVP Roadmap

MVP Roadmap

Phase 1: LTV/CAC Optimization & B2B Foundation

Months 1-3

Stabilize B2C unit economics (LTV:CAC > 2.0x) and prepare technical/compliance foundation for B2B sales.

Features
  • -Implement strict B2C paywall analytics to measure true WTP.
  • -Build provider dashboard MVP for B2B2C pilot.
  • -Achieve HIPAA compliance certification.
Success Metrics
  • +B2C LTV:CAC > 2.0x.
  • +HIPAA audit passed.
  • +Provider dashboard MVP demo-ready.

Phase 2: B2B2C Pilot & RTM Integration

Months 4-6

Prove the B2B2C model works, pharmacies will distribute it, and RTM billing can be successfully claimed.

Features
  • -Deploy MedElder to 500 patients via 2 regional pharmacy partners.
  • -Integrate with RTM billing middleware (e.g., Redox).
  • -Automate patient onboarding at pharmacy counter.
Success Metrics
  • +2 signed pharmacy pilot agreements.
  • +500 active B2B2C patients.
  • +First successful RTM billing claim processed.

Phase 3: Regional Scale & EHR Deep Integration

Months 7-12

Achieve product-market fit in the B2B2C channel and establish a defensible regional moat.

Features
  • -Direct API integration with local EHR systems for seamless data flow.
  • -Automated RTM reporting and billing dashboard for clinics.
  • -Expand to 10 regional pharmacy networks.
Success Metrics
  • +$30k MRR from B2B2C contracts.
  • +Net Revenue Retention (NRR) > 110%.
  • +10,000 total active patients.

Team Requirements

Team Size

3-4 core members, leveraging contractors for HIPAA compliance audits.

Timeline

3 months to B2B2C Pilot MVP.

Required Roles
Founder/CEO (Focus on B2B sales and healthcare strategy)Technical Co-founder (Focus on API integrations, EHR middleware, HIPAA security)B2B Enterprise Sales Lead (Healthcare/Pharmacy background)

Tech Stack

Complexity:HIGH
Recommended Stack
Backend: Node.js/Python with strict HIPAA-compliant cloud hosting (AWS GovCloud or specialized healthcare clouds like HealthCloud).Integration: Redox or Health Gorilla APIs for EHR/Pharmacy data aggregation.Frontend: React Native for cross-platform mobile, React for provider web dashboard.
Scalability Notes

Architecture must support real-time webhook processing for missed-dose alerts and high-volume RTM data reporting without latency. Data encryption at rest and in transit is non-negotiable.

Initial Steps

1

Audit current B2C unit economics (CAC, LTV, churn by cohort).

Clear data on whether the current B2C model is sustainable or bleeding cash.

2

Interview 5 regional pharmacy owners about their adherence tracking and RTM billing pain points.

Validation of the B2B2C wedge and identification of the exact workflow integration required.

3

Initiate HIPAA compliance and SOC2 Type 1 preparation.

Removal of the primary blocker for selling to healthcare providers.

Validation Checklist

StatusActionSuccess CriteriaFailure CriteriaTime Estimate
Conduct 10 discovery calls with independent/regional pharmacy owners.At least 3 express strong interest in a patient adherence tool that handles RTM billing.0 interest, or they state they already use Medisafe/Medical GPS and are happy.2 weeks
Build a clickable Figma prototype of the Provider Dashboard and RTM billing flow.Pharmacy owners can clearly articulate how it saves them time/money.Confusion about the workflow, or they refuse to look at it because 'tech doesn't work in our clinic'.1 week
Secure 1 Letter of Intent (LOI) from a regional pharmacy to pilot the B2B2C model.Signed LOI agreeing to deploy to 50 patients for a 90-day pilot.Inability to get a meeting, or refusal to sign any pilot agreement.4 weeks

Offline Validation Guide

Assignments

1

B2C Unit Economics Audit

Budget: $0 (Internal analysis)Method: Extract Mixpanel/Amplitude data to calculate true LTV, CAC, and cohort retention for existing paying users.: Week 1
2

Healthcare Compliance Scoping

Budget: $2,000Method: Hire a fractional HIPAA compliance officer to audit current architecture and provide a remediation roadmap.: Week 2
3

B2B Pitch Deck Creation

Budget: $500 (Design)Method: Draft a 10-slide deck specifically for regional pharmacy owners focusing on RTM revenue share and patient outcomes.: Week 3

Brand Archetype

The Compassionate Guardian

MedElder embodies the Caregiver archetype, focusing on protection, peace of mind, and ensuring loved ones are safe and healthy without burdening them with complex technology.

Empathetic and reassuring.Focuses on safety and well-being.Simplifies complex tasks to protect the vulnerable.
Brand Voice

Calm, reassuring, clear, and professional. Avoids medical jargon; speaks directly to the anxieties of the adult child caregiver.

Visual Style

Soft, high-contrast colors (blues and greens for trust/health), large typography for accessibility, clean and uncluttered interfaces.

Recommendation

Lean heavily into the 'peace of mind for the caregiver' messaging in B2C, and 'revenue/reimbursement without the headache' messaging in B2B.

Pitch Deck

One Liner

MedElder turns medication adherence into a reimbursable healthcare service for pharmacies and peace of mind for families.

Elevator Pitch

Every year, medication non-adherence causes 125,000 deaths and costs the US healthcare system $289B. Families rely on $4 plastic pillboxes, while pharmacies lose revenue. MedElder provides a simple, senior-friendly app that tracks adherence and integrates directly with pharmacy workflows. By leveraging CMS Remote Therapeutic Monitoring (RTM) policies, we allow pharmacies to bill for adherence, turning a cost center into a revenue stream, while giving families real-time peace of mind.

Problem

Medication non-adherence is a silent killer. For families, managing a parent's meds is a constant source of anxiety. For pharmacies, ensuring patients take their meds is uncompensated work. Current solutions are either too complex (apps) or too dumb (plastic organizers), leaving a massive gap in the care continuum.

Solution

MedElder is the bridge between the patient, the caregiver, and the pharmacy. A zero-setup app for seniors, a real-time dashboard for families, and an RTM-integrated workflow for pharmacies that turns adherence tracking into a billable medical event.

Market Size

The Medication Tracker App market is $1.76B and growing at 14% CAGR. But the real opportunity is the $4.8B Medication Adherence market. With the 'Peak 65' demographic and new CMS RTM billing codes, the silver economy is shifting from consumer convenience to reimbursable healthcare infrastructure.

Competitive Landscape

Medisafe dominates B2C but ignores the provider revenue workflow. Amazon PillPack solves logistics but locks patients into their pharmacy and offers no caregiver API. MedElder is the only platform built specifically to unlock RTM revenue for independent and regional pharmacies.

Business Model

We operate a B2B2C model. The app is free for patients, subsidized by the pharmacy. We charge pharmacies a SaaS fee ($3/patient/mo) and take a percentage of the RTM reimbursement revenue we help them generate. This aligns incentives and drastically lowers CAC.

Funding Ask

Raising $750k Seed. Funds will be allocated to achieving HIPAA/SOC2 compliance, building the EHR integration middleware, and hiring a dedicated healthcare sales team to secure our first 10 regional pharmacy partners.

Tips

  • Click the copy button on each slide and paste into PPT or Google Slides
  • Use with concise visuals and data charts for best results
  • Elevator pitch and one-liner can be used for social media bios or pitch emails

Strategic Opportunities

Potential Partners

Pharmacy Data Aggregators

SurescriptsHealth GorillaRedox

Partnering with these companies provides immediate, compliant access to pharmacy fill data and EHR systems without building custom integrations from scratch.

Medicare Advantage Plans

HumanaUnitedHealthcareRegional MA Plans

MA plans are desperate to improve their CMS Star Ratings (which dictate their reimbursement). MedElder can be sold to the plan, who then distributes it to their members for free.

Distribution Channels

Independent & Regional Pharmacy Networks
Medicare Advantage Plan Member Portals
Home Care Agencies (as part of their care package)
Alzheimer's & Dementia Caregiver Support Groups
Discharge Planners at Regional Hospitals
AARP and Senior Advocacy Organizations

Exit Opportunity

Timeline

5-7 years

Valuation Range

$50M - $150M (assuming $5M-$10M ARR with strong B2B2C retention)

Potential Acquirers

Pharmacy Benefit Managers (PBMs) like CVS Caremark or ExpressScripts looking to improve adherence.Health Tech Giants like Teladoc or Amwell expanding into chronic care management.Private Equity firms specializing in healthcare roll-ups.

Related Reports

Browse by industry:SaaS·AI/ML·Fintech·Failure Cases·Free Tools

Thinking About Building a Startup Tool?

The startup market is $1.76 Billion in 2025 (Source: wiseguyreports.com). Calculated as global medication tracker apps market, growing to $6.5B by 2035 at 14% CAGR. and growing. Get your complete validation report with market research, competitor analysis, and financial projections in 4 minutes.

Validate Your Startup Idea →